Jim Cramer reminds investors that market pain is needed to prevent endless price hikes

Jim Cramer reminds investors that market pain is needed to prevent endless price hikes


CNBC’s Jim Cramer on Thursday reminded investors that pain in the stock market is unfortunately necessary for the Federal Reserve to win against inflation.

“Nobody wants to root for layoffs or lower stock prices. But the alternative is persistently high inflation — endless price increases for everything — and nobody wants that either,” he said.

Stocks fell on Thursday after fresh data indicated that the labor market remains strong, despite the Fed’s aggressive interest rate hikes to tamp down rising prices. 

Cramer explained that while the Fed needs to make it so that companies can no longer raise prices for goods and services, it’s inevitable that such an outcome will hurt portfolios.

“Lower home prices – it’s good if you’re looking for a house, but it’s awful if you own shares in homebuilder Lennar,” he said as an example. “In other words, there’s no free lunch for you, the investor.”

And while it’s unclear when the central bank will be able to roll back its interest rate increases and stop hurting the market, he said that the release of the nonfarm payrolls report on Friday will shed more light on the state of inflation.

“If it doesn’t show higher unemployment with no wage growth, the Fed will need to keep aggressively raising interest rates,” Cramer said.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More